MMSIMerit Medical Systems, Inc.

$87.22+4.4% 1Y

$87.22

$60.3152 weeks$93.18

MMSI in its own filings

MMSI's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.

452

Events found in the filings · across 1,663 filings · the record starts in 1996

Hard flags: 1
Hard flags
Most recent filing: Aug 20, 2026
Most recent filing · Form 8-K
Record starts: May 14, 1996
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Oct 29, 2026
Delisting notice / listing-rule failurehistorical: 2011-09-28
SEC comment-letter activity33 occurrences: 2024-09-06

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Aug 20, 2026On August 14, 2026, Merit Medical Systems, Inc. (“Merit”) reorganized portions of its global operations function. As a result of such reorganization, the position of Chief Operating Officer was eliminated, and Neil W. Peterson’s title was changed to Senior Advisor.Director or officer change · Form 8-K
Jul 30, 2026Reported revenue of $418.8 million, up 10%.Earnings release · press release
May 19, 2026At the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Merit Medical Systems, Inc. (the “Company”) held on May 13, 2026, the Company’s shareholders approved (i) the Merit Medical Systems, Inc. 2026 Equity Incentive Plan (the “EIP”) and (ii) the Merit Medical Systems, Inc. 2026 Employee Stock Purchase …Director or officer change · Form 8-K
Apr 30, 2026Reported revenue of $381.9 million, up 7%.Earnings release · press release
Apr 1, 2026Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio.Regulation FD disclosure · press release
Feb 24, 2026Fourth Quarter Highlights†.Earnings release · press release
Jan 8, 2026As further discussed in the attached press release, Fred P. Lampropoulos resigned as a director and Chair of Merit’s Board of Directors (the “Board”), effective January 4, 2026, citing personal reasons.Earnings release · Form 8-K
Nov 13, 2025Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis.Regulation FD disclosure · press release
Oct 30, 2025Reported revenue of $384.2 million, up 13.0%.Earnings release · press release
Oct 17, 2025Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to acquire C2 CryoBalloon Technology.Regulation FD disclosure · press release